Literature DB >> 28566119

Consultation expectations among patients with respiratory tract infection symptoms.

Gitte Bruun Lauridsen1, Mette Sejr Sørensen, Malene Plejdrup Hansen, Jette Østergaard Rathe, Dorte Ejg Jarbøl.   

Abstract

INTRODUCTION: Antibiotic resistance is a growing threat to public health, and antibiotic prescribing increases. About 90% of antibiotics are prescribed in general practice, mostly for acute respiratory tract infections. It is well known that patient expectations and general practitioners' misinterpretation of patients' expectations are associated with antibiotic overuse. The aim of this study was to explore Danish patients' expectations when consulting a general practitioner with symptoms of acute respiratory tract infection, and to determine predictors for these expectations.
METHODS: A questionnaire survey was conducted in Danish primary care during 2014. Patients aged ≥ 18 years were asked about their expectations to the consultation when consulting with symptoms of acute respiratory tract infections. Associations between socio-demographic characteristics, self-reported antibiotic prescription and patients' expectations were also explored.
RESULTS: A total of 567 patients with symptoms of acute respiratory tract infections were recorded as interested in receiving a questionnaire, 361 of whom responded. The majority expected an examination (94.6%) and an explanation (85.9%). About one third expected antibiotic treatment (32.3%). Patients who expected an antibiotic were more than eight times more likely to be prescribed one than were patients not expecting an antibiotic (odds ratio = 8.6 (95% confidence interval: 4.63-16.03); p < 0.001).
CONCLUSIONS: Most Danish patients expected an examination and/or an explanation of their symptoms when consulting with their general practitioner. FUNDING: The study was, in part, funded by The Council for Quality Assurance in Primary Care in both The Region of Southern Denmark and Region Zealand. Malene Plejdrup Hansen received a postdoctoral scholarship in general practice and family medicine from The Novo Nordic Foundation. The sponsors have not been involved in the design or the development of the study. TRIAL REGISTRATION: This study was registered with the Danish Data Protection Agency (R. no. 2013-41-2582). Articles published in the DMJ are “open access”. This means that the articles are distributed under the terms of the Creative Commons Attribution Non-commercial License, which permits any non-commercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28566119

Source DB:  PubMed          Journal:  Dan Med J        ISSN: 2245-1919            Impact factor:   1.240


  4 in total

1.  Understanding determinants of patients' decisions to attend their family physician and to take antibiotics for upper respiratory tract infections: a qualitative descriptive study.

Authors:  Sameh Mortazhejri; Andrea M Patey; Dawn Stacey; R Sacha Bhatia; Alykhan Abdulla; Jeremy M Grimshaw
Journal:  BMC Fam Pract       Date:  2020-06-24       Impact factor: 2.497

2.  Evaluation of a multimodal intervention to promote rational antibiotic use in primary care.

Authors:  Inga Petruschke; Florian Salm; Michelle Kaufmann; Antje Freytag; Jochen Gensichen; Michael Behnke; Tobias Siegfried Kramer; Regina Hanke; Petra Gastmeier; Sandra Schneider
Journal:  Antimicrob Resist Infect Control       Date:  2021-04-06       Impact factor: 4.887

3.  [Acute respiratory tract infections and antibiotic prescriptions: What are patients' expectations?]

Authors:  Anja Wollny; Attila Altiner; Katharina Garbe; Anja Klingenberg; Petra Kaufmann-Kolle; Martina Köppen; Martina Kamradt; Regina Poß-Doering; Michel Wensing; Mirko Leyh; Arwed Voss; Gregor Feldmeier
Journal:  Dtsch Med Wochenschr       Date:  2022-08-16       Impact factor: 0.653

4.  Patients' experiences of the use of point-of-care ultrasound in general practice - a cross-sectional study.

Authors:  Camilla Aakjær Andersen; John Brodersen; Torsten Rahbek Rudbæk; Martin Bach Jensen
Journal:  BMC Fam Pract       Date:  2021-06-18       Impact factor: 2.497

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.